Neurofibromatosis Type 2
by Cynthia M. Johnson, MA
Neurofibromatosis is an inherited problem that causes tumors in the nervous system. They happen in the nerves or the tissue that surrounds them. Neurofibromatosis has three types: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. The type a person has depends on the genes that are affected.
This article focuses on NF2. These tumors tend to happen in the central nervous system. The eighth cranial nerve is the one most affected. It affects hearing and balance.
NF2 is caused by a faulty gene. The gene normally makes proteins that help control growth in the nerves. A faulty gene is not able to make these proteins and tumors develop.
In most people, the faulty gene is passed down from a parent. The gene change can also happen in a person who does not have other family members with NF2.
This risk of this problem is highest in people who have other family members with the disease.
The problems a person has depends on the size of the tumor and where it is. Smaller ones may not cause symptoms.
Problems may be:
The doctor will ask about your medical and health history. You will also be asked about your family medical history. A physical exam will be done. It may take a few years before NF2 is diagnosed.
These tests may be done:
There is no cure. People who do not have symptoms may not need to be treated. The tumors are rarely cancerous and grow slowly. A specialist will watch for any changes.
People who do have symptoms may need:
There are no guidelines to prevent this health problem.
Children's Tumor Foundation
Brain Tumour Foundation of Canada
The Tumour Foundation of BC
Intro to NF. Children's Tumor Foundation website. Available at: https://www.ctf.org/understanding-nf/nf2. Accessed February 12, 2021.
Neurofibromatosis type 2. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/neurofibromatosis-type-2. Accessed February 12, 2021.
Neurofibromatosis information page. National Institute of Neurological Disorders and Stroke website. Available at: https://www.ninds.nih.gov/Disorders/All-Disorders/Neurofibromatosis-Information-Page. Accessed February 12, 2021.
Ruggieri M, Praticò AD, et al. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms. Semin Pediatr Neurol. 2015 Dec;22(4):240-258.
Last reviewed December 2020 by EBSCO Medical Review Board James P. Cornell, MD
Last Updated: 2/12/2021
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.
All rights reserved.